Velusetrag
A medication used for the treatment of gastrointestinal disorders
| Velusetrag | |
|---|---|
|
|
Velusetrag is a medication that acts as an agonist of the 5-HT4 receptor, which is a subtype of the serotonin receptor. It is primarily used in the treatment of certain gastrointestinal disorders, particularly those involving motility issues.
Mechanism of Action[edit]
Velusetrag works by stimulating the 5-HT4 receptors in the gastrointestinal tract. This action enhances the release of acetylcholine, a neurotransmitter that promotes peristalsis and increases gastrointestinal motility. By activating these receptors, Velusetrag helps to alleviate symptoms associated with conditions like chronic idiopathic constipation and gastroparesis.
Clinical Uses[edit]
Velusetrag is primarily indicated for the treatment of chronic idiopathic constipation. It has been studied for its potential benefits in other motility disorders, such as gastroparesis, where delayed gastric emptying is a significant concern. Clinical trials have demonstrated its efficacy in improving bowel movement frequency and reducing associated symptoms.
Side Effects[edit]
Common side effects of Velusetrag include headache, nausea, and diarrhea. These effects are generally mild to moderate in severity. As with any medication, there is a potential for more serious adverse effects, and patients are advised to consult their healthcare provider if they experience any unusual symptoms.
Pharmacokinetics[edit]
Velusetrag is administered orally and is well absorbed in the gastrointestinal tract. It undergoes hepatic metabolism and is excreted primarily in the urine. The pharmacokinetic profile of Velusetrag supports its use as a once-daily medication, which can improve patient compliance.
Research and Development[edit]
Velusetrag was developed as part of ongoing research into 5-HT4 receptor agonists, which have shown promise in treating various gastrointestinal disorders. The development of Velusetrag involved extensive clinical trials to establish its safety and efficacy profile.
Related Pages[edit]
References[edit]
-
Structure of Velusetrag
-
Another view of Velusetrag
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian